Evaluation of the Bactericidal Activity of Fosfomycin in Combination with Selected Antimicrobial Comparison Agents Tested against Gram-Negative Bacterial Strains by Using Time-Kill Curves

被引:2
作者
Flamm, Robert K. [1 ]
Rhomberg, Paul R. [1 ]
Lindley, Jill M. [1 ]
Sweeney, Kim [2 ]
Ellis-Grosse, E. J. [2 ]
Shortridge, Dee [1 ]
机构
[1] JMI Labs, North Liberty, IA 52317 USA
[2] Zavante Therapeut Inc, San Diego, CA USA
关键词
fosfomycin; synergy; IN-VITRO; KLEBSIELLA-PNEUMONIAE; COLISTIN; ENTEROBACTERIACEAE; SUSCEPTIBILITY; TIGECYCLINE; RIFAMPIN;
D O I
10.1128/AAC.02549-18
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The effects of combining fosfomycin with various antimicrobial agents were evaluated in vitro by broth microdilution checkerboard and time-kill kinetic studies. Checkerboard analyses were used to evaluate the following 30 Gram-negative isolates: 5 Pseudomonas aeruginosa, 5 Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, and 20 Enterobacteriaceae isolates. No isolate exhibited antagonism when fosfomycin was tested in combination, and synergy was observed in more than 25% of the drug combinations tested. The most frequent instances of synergy occurred when testing fosfomycin with beta-lactams. Two isolates of Pseudomonas aeruginosa, 2 of Klebsiella pneumoniae, and 1 of the A. baumannii-A. calcoaceticus species complex that exhibited synergy when fosfomycin was tested in combination were subjected to time-kill kinetic analyses for confirmation. Time-kill assays confirmed synergistic activity. These data indicated that combination therapy with fosfomycin may be beneficial.
引用
收藏
页数:8
相关论文
共 33 条
  • [1] The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments
    Albur, Mahableshwar S.
    Noel, Alan
    Bowker, Karen
    MacGowan, Alasdair
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 46 (05) : 560 - 567
  • [2] Allergan, 2014, MON PACK INS
  • [3] In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii
    Bae, Seongman
    Kim, Min-Chul
    Park, Su-Jin
    Kim, Hee Sueng
    Sung, Heungsup
    Kim, Mi-Na
    Kim, Sung-Han
    Lee, Sang-Oh
    Choi, Sang-Ho
    Woo, Jun Hee
    Kim, Yang Soo
    Chong, Yong Pil
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (11) : 6774 - 6779
  • [4] In Vitro Activities of Combinations of Rifampin with Other Antimicrobials against Multidrug-Resistant Acinetobacter baumannii
    Bai, Yan
    Liu, Bin
    Wang, Tianlin
    Cai, Yun
    Liang, Beibei
    Wang, Rui
    Liu, Youning
    Wang, Jin
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (03) : 1466 - 1471
  • [5] Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae
    Ballestero-Tellez, M.
    Docobo-Perez, F.
    Rodriguez-Martinez, J. M.
    Conejo, M. C.
    Ramos-Guelfo, M. S.
    Blazquez, J.
    Rodriguez-Bano, J.
    Pascual, A.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (05) : 325 - 331
  • [6] Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3-or OXA-48-producing Escherichia coli
    Berleur, M.
    Guerin, F.
    Massias, L.
    Chau, F.
    Poujade, J.
    Cattoir, V.
    Fantin, B.
    de lastours, V.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (11) : 3074 - 3080
  • [7] Susceptibility of anaerobes to fusidic acid and fosfomycin
    Boyanova, Lyudmila
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (05) : 560 - 561
  • [8] Clinical and Laboratory Standards Institute, 2017, M100S27 CLIN LAB STA
  • [9] Clinical and Laboratory Standards Institute, 2018, M23ED5E CLIN LAB STA
  • [10] Clinical and Laboratory Standards Institute, 2015, M07A10 CLIN LAB STAN